You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

Drug Sales Trends for ESCITALOPRAM


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for ESCITALOPRAM (2020)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $48,103,821
INSIDE ANOTHER STORE $147,746,996
[disabled in preview] $261,029,321
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 2,443,351
INSIDE ANOTHER STORE 8,273,200
[disabled in preview] 19,504,950
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $64,385,953
MEDICARE $69,400,369
[disabled in preview] $323,093,815
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ESCITALOPRAM
Drug Units Sold Trends for ESCITALOPRAM

Annual Sales Revenues and Units Sold for ESCITALOPRAM

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ESCITALOPRAM ⤷  Try a Trial ⤷  Try a Trial 2019
ESCITALOPRAM ⤷  Try a Trial ⤷  Try a Trial 2018
ESCITALOPRAM ⤷  Try a Trial ⤷  Try a Trial 2017
ESCITALOPRAM ⤷  Try a Trial ⤷  Try a Trial 2016
ESCITALOPRAM ⤷  Try a Trial ⤷  Try a Trial 2015
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.